Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001214946 | SCV001386655 | likely benign | Nemaline myopathy 2 | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004033948 | SCV004980672 | uncertain significance | Inborn genetic diseases | 2023-10-14 | criteria provided, single submitter | clinical testing | The c.8224G>C (p.E2742Q) alteration is located in exon 59 (coding exon 57) of the NEB gene. This alteration results from a G to C substitution at nucleotide position 8224, causing the glutamic acid (E) at amino acid position 2742 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001214946 | SCV002079629 | uncertain significance | Nemaline myopathy 2 | 2020-03-17 | no assertion criteria provided | clinical testing |